JERICHO SCIENCES Trademark

Trademark Overview


On Monday, August 23, 2021, a trademark application was filed for JERICHO SCIENCES with the United States Patent and Trademark Office. The USPTO has given the JERICHO SCIENCES trademark a serial number of 90896357. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 2, 2023. This trademark is owned by Jericho Sciences, LLC. The JERICHO SCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis ...
jericho sciences

General Information


Serial Number90896357
Word MarkJERICHO SCIENCES
Filing DateMonday, August 23, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Goods and ServicesAntivirals; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents; Ocular pharmaceuticals; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; Syringes sold filled with pharmaceuticals for treating infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Disclaimer with Predetermined Text"SCIENCES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJericho Sciences, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 277093169

Party NameJericho Sciences, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 277093169

Trademark Events


Event DateEvent Description
Monday, October 2, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022NON-FINAL ACTION WRITTEN
Wednesday, May 25, 2022ASSIGNED TO EXAMINER
Friday, October 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2021NEW APPLICATION ENTERED